Author name: cultivate(MD)

Virtual Incision cultivate(MD)

cultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officer 

RAND RAPIDS, MI – June 24, 2025 – cultivate(MD), a leading medical device venture capital company, is pleased to announce that its portfolio company, Virtual Incision Corporation, the developer of the MIRA Surgical System authorized by the FDA through the De Novo regulatory pathway, has appointed Jim Alecxih as chief executive officer. Alecxih, a recognized commercial leader in the medical device industry, […]

cultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officer  Read More »

HAPPE Spine MTI news

HAPPE Spine Selected for MedTech Innovator 2025 Accelerator Cohort

We’re proud to share that HAPPE Spine, a portfolio company of cultivate(MD), has been selected for the MedTech Innovator 2025 Accelerator Cohort, an honor reserved for the top 4% of nearly 1,500 global applicants. This recognition reflects both the strength of HAPPE’s mission and the game-changing potential of their breakthrough spinal implant technology. MedTech Innovator

HAPPE Spine Selected for MedTech Innovator 2025 Accelerator Cohort Read More »

SPDx cultivate(MD) news

cultivate(MD) Announces Acquisition of Portfolio Company SPDx by Instrumentum

Grand Rapids, MI – June 11, 2025 – cultivate(MD), a leading medical device venture capital company, is pleased to announce the acquisition of its portfolio company, Sterile Processing Express (SPDx), by Instrumentum, LLC, a fast-growing leader in surgical instrument sterilization services.  This strategic acquisition expands Instrumentum’s operational footprint to five facilities across four states, significantly enhancing its capacity

cultivate(MD) Announces Acquisition of Portfolio Company SPDx by Instrumentum Read More »